Post type for adding timeline express announcements to the site
PCF convenes leading cancer researchers, elected officials and philanthropists at the Charlottesville, Virginia home of John Kluge for the “Call to Action” dinner. The goal of the evening is to map out the future of medical research – and figure…
PCF organizes the first-ever National Cancer Summit in Washington, where Mike outlines a 10-point plan to rethink the war on cancer. Most of the ten points – listed below – have since been achieved by PCF, FasterCures and other organizations:…
Mike and his family are shocked when his doctor delivers those three dreaded words: “You have cancer.” Worse, his advanced prostate cancer has spread to his lymph nodes and registers a score of 9 out of 10 on the Gleason…
One million four-hundred thousand more men are alive today than was projected when PCF was founded in 1993. That’s enough to fill 28 Yankee Stadiums. And 99% of men diagnosed with the disease today can expect to survive past the…
A record 23 chemically distinct, “first-in-field” anti-prostate cancer medicines enter clinical trials within a 12–month window.
PCF creates multidisciplinary Dream Teams of precision oncology researchers. Xofigo – a unique alpha particle that’s been shown to be effective in treating metastatic disease – becomes the sixth new drug treatment in three years to receive FDA approval. The…
PCF further expands internationally with its first two Young Investigator Awards in China. The FDA approves a fifth new treatment for prostate cancer – Xtandi, used for Lupron-resistant disease, reduces PSA levels up to 89% after one month. And in…
The wave of new prostate cancer treatments continues as the FDA approves Zytiga, a novel anti-androgen that puts more than 40% of men with Lupron-resistant disease back in remission. Meanwhile, during the week following the annual PCF Scientific Retreat, key…
Three new drug treatments for advanced prostate cancer – each with significant contributions from PCF-funded researchers – are approved by the FDA: Provenge (April), Jevtana (June) and Xgeva (November). Provenge is a first-of-its kind immunotherapy that stimulates a patient’s immune…
Jonathan Simons, who a decade earlier was one of the earliest grant recipients from the organization, is named President and CEO of PCF. Read Dr. Simons Bio here: pcf.org/bio/jonathan-w-simons-md
Fortune magazine calls Mike “The Man Who Changed Medicine,” stressing the changes he wrought rather than the checks he wrote: “Now thousands are living longer – and leaders everywhere are taking notice.” As the organization measures a decade of advances…
PCF – which before 2003 was known as CaP CURE – adopts its new name. Simultaneously, the “CURE” part of the old organization becomes FasterCures, a center of the Milken Institute dedicated to accelerating progress against all life-threatening diseases.
Staying true to PCF’s founding commitment to the importance of prevention and nutrition, Mike publishes The Taste for Living Cookbook with cancer-fighting recipes. A second cookbook – with international recipes – would follow a year later.
PCF organizes “THE MARCH: Coming Together to Conquer Cancer.” Hundreds of thousands of participants, including representatives from 600 disease organizations, gather on the National Mall and around the country to demand greater research funding. Later that year, Congress passes legislation…
Recognizing that there’s no better way to communicate with American men than through the national pastime, PCF leadership meets with Major League Baseball team owners Jerry Reinsdorf, Fred Wilpon and Peter Magowan to brainstorm on ways the organizations can partner.…
Unlike many other forms of the disease, prostate cancer had never had vocal and effective advocates. Men were naturally reticent to discuss such a personal disease, and few prospects existed for better treatments. PCF changed that. Several high-profile media engagements…
The PCF hosts its first annual Scientific Retreat in Santa Barbara. The rules are clear: if you accept PCF funding, you must return each year and share your research findings. On the Retreat’s opening day, the medical researchers sit with…
When Mike launches the PCF, prostate cancer patients and their families face a bleak outlook. More than 200,000 American men will be diagnosed in 1993, and 44,000 will lose their battle that year. Forecasters project the number will rise significantly…
Formalizing his earlier philanthropy, Mike establishes the Milken Family Foundation with his brother Lowell. Medical research is among the philanthropy’s major areas of focus. Starting in the mid-1980s, MFF supports a cadre of young cancer researchers whose work opens several…
Mike’s father Bernard is told the malignant melanoma he had been diagnosed with two years earlier is terminal. The doctors say nothing can be done, but Mike refuses to accept that prognosis. He takes his father to leading melanoma experts…
Three years after Mike Milken begins his legendary career on Wall Street, his wife Lori informs him of the terrible news that her mother has been diagnosed with breast cancer. Mike begins his education about medical research – an area…
